Clinical Trials Directory

Trials / Unknown

UnknownNCT03205020

Maternal Serum Amyloid A Levels in Pregnancies Complicated With Preterm Labour.

Status
Unknown
Phase
Study type
Observational
Enrollment
58 (estimated)
Sponsor
mona nematallah · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

The aim of the current study is to assess the accuracy of maternal serum amyloid A for prediction of preterm labor in women with threatened preterm labor.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTserum amyloid a test* Women who are diagnosed with preterm labor (28-36 weeks) will be enrolled in this study. Serum samples will be collected from all women before any intervention. All women will be sampled once at the time of admission. * Venous blood sample (5 c.c) will be taken from each participant for examination of serum amyloid A. * The collected blood will be centrifuging and serum will be stored to measure the level of amyloid A by (ELISA) technique in clinical pathology department- Ain shams University

Timeline

Start date
2017-07-01
Primary completion
2018-01-01
Completion
2018-02-01
First posted
2017-07-02
Last updated
2017-07-05

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT03205020. Inclusion in this directory is not an endorsement.